New Zealand markets close in 5 hours 13 minutes

Spruce Biosciences, Inc. (SPRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1600-0.1000 (-4.42%)
At close: 04:00PM EDT
2.1200 -0.04 (-1.85%)
After hours: 04:10PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 92.41M
Enterprise value -22.60M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.37
Price/book (mrq)0.95
Enterprise value/revenue -5.47
Enterprise value/EBITDA 0.47

Trading information

Stock price history

Beta (5Y monthly) 2.13
52-week change 366.18%
S&P500 52-week change 316.57%
52-week high 33.5700
52-week low 30.9550
50-day moving average 32.2792
200-day moving average 32.2347

Share statistics

Avg vol (3-month) 370.3k
Avg vol (10-day) 326.38k
Shares outstanding 540.71M
Implied shares outstanding 640.71M
Float 812.45M
% held by insiders 10.44%
% held by institutions 191.76%
Shares short (14 Sept 2023) 482.05k
Short ratio (14 Sept 2023) 40.77
Short % of float (14 Sept 2023) 40.26%
Short % of shares outstanding (14 Sept 2023) 40.20%
Shares short (prior month 14 Aug 2023) 431.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin 0.00%
Operating margin (ttm)-1,231.24%

Management effectiveness

Return on assets (ttm)-27.57%
Return on equity (ttm)-51.87%

Income statement

Revenue (ttm)4.13M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -50.75M
Net income avi to common (ttm)-48.16M
Diluted EPS (ttm)-1.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)120.52M
Total cash per share (mrq)2.96
Total debt (mrq)5.51M
Total debt/equity (mrq)5.71%
Current ratio (mrq)5.46
Book value per share (mrq)2.37

Cash flow statement

Operating cash flow (ttm)-30.11M
Levered free cash flow (ttm)-16.57M